Schott Pharma Ag & CO Kgaa (1SXP.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 253,587 | 234,202 | 232,251 | 228,516 | 221,353 |
| Cost of Goods | 166,505 | 155,126 | 148,502 | 154,219 | 147,277 |
| Gross Profit | 87,082 | 79,076 | 83,749 | 74,297 | 74,076 |
| Operating Expenses | 32,642 | 53,497 | 28,192 | 47,926 | 24,105 |
| Operating Income | 54,440 | 25,579 | 55,557 | 26,371 | 49,971 |
| Interest Expense | 3,663 | 2,909 | 2,554 | 2,410 | 1,989 |
| Other Income | 5,143 | 3,725 | 2,646 | 12,289 | -8,211 |
| Pre-tax Income | 55,920 | 26,395 | 55,649 | 36,250 | 39,771 |
| Income Tax | 9,481 | 1,199 | 11,130 | 1,543 | 9,214 |
| Net Income Continuous | 46,439 | 25,196 | 44,519 | 34,707 | 30,557 |
| Minority Interests | -175 | -161 | -107 | -8 | -70 |
| Net Income | $46,264 | $25,035 | $44,412 | $34,699 | $30,487 |
| EPS Basic Total Ops | 0.31 | 0.17 | 0.29 | 0.23 | 0.20 |
| EPS Basic Continuous Ops | 0.31 | 0.17 | 0.29 | 0.23 | N/A |
| EPS Diluted Total Ops | 0.31 | 0.17 | 0.29 | 0.23 | 0.20 |
| EPS Diluted Continuous Ops | 0.31 | 0.17 | 0.29 | 0.23 | N/A |
| EBITDA(a) | $76,086 | $45,142 | $72,839 | $57,719 | $55,159 |